These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. "We as Human Beings Get Farther and Farther Apart": the experiences of patients with remote monitoring systems. Ottenberg AL; Swetz KM; Mueller LA; Gerhardson S; Mueller PS Heart Lung; 2013; 42(5):313-9. PubMed ID: 23582212 [TBL] [Abstract][Full Text] [Related]
44. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator. Daimee UA; Vermilye K; Moss AJ; Goldenberg I; Klein HU; McNitt S; Zareba W; Kutyifa V Heart Rhythm; 2018 Sep; 15(9):1379-1386. PubMed ID: 29678779 [TBL] [Abstract][Full Text] [Related]
45. Implantable cardioverter defibrillator therapy in young patients with cardiomyopathies and channelopathies: a single Italian centre experience. Migliore F; Silvano M; Zorzi A; Bertaglia E; Siciliano M; Leoni L; De Franceschi P; Iliceto S; Corrado D J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):485-93. PubMed ID: 27136702 [TBL] [Abstract][Full Text] [Related]
47. A link to better care: The effect of remote monitoring on long-term adverse cardiac events in a propensity score-matched cohort. Portugal G; Cunha P; Valente B; Feliciano J; Lousinha A; Alves S; Braz M; Pimenta R; Delgado AS; Oliveira M; Ferreira RC Rev Port Cardiol; 2017 Mar; 36(3):189-195. PubMed ID: 28258782 [TBL] [Abstract][Full Text] [Related]
48. Association between remote implantable cardioverter defibrillator monitoring and beta-blocker utilization: An analysis from the EFFECT study. D'Onofrio A; Stabile G; Capucci A; Amellone C; De Simone A; Leoni L; Morani G; Bianchi V; Campari M; Valsecchi S; Buja G; J Telemed Telecare; 2016 Oct; 22(7):383-90. PubMed ID: 26703214 [TBL] [Abstract][Full Text] [Related]
49. Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study. Boersma L; Barr C; Knops R; Theuns D; Eckardt L; Neuzil P; Scholten M; Hood M; Kuschyk J; Jones P; Duffy E; Husby M; Stein K; Lambiase PD; J Am Coll Cardiol; 2017 Aug; 70(7):830-841. PubMed ID: 28797351 [TBL] [Abstract][Full Text] [Related]
50. Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States. Friedman DJ; Parzynski CS; Varosy PD; Prutkin JM; Patton KK; Mithani A; Russo AM; Curtis JP; Al-Khatib SM JAMA Cardiol; 2016 Nov; 1(8):900-911. PubMed ID: 27603935 [TBL] [Abstract][Full Text] [Related]
51. Economic analysis of remote monitoring of cardiac implantable electronic devices: Results of the Health Economics Evaluation Registry for Remote Follow-up (TARIFF) study. Ricci RP; Vicentini A; D'Onofrio A; Sagone A; Rovaris G; Padeletti L; Morichelli L; Fusco A; De Vivo S; Lombardi L; Denaro A; Pollastrelli A; Colangelo I; Santini M Heart Rhythm; 2017 Jan; 14(1):50-57. PubMed ID: 27614025 [TBL] [Abstract][Full Text] [Related]
52. The Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients. Varma N; Piccini JP; Snell J; Fischer A; Dalal N; Mittal S J Am Coll Cardiol; 2015 Jun; 65(24):2601-2610. PubMed ID: 25983008 [TBL] [Abstract][Full Text] [Related]
53. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators. Rosenqvist M; Beyer T; Block M; den Dulk K; Minten J; Lindemans F Circulation; 1998 Aug; 98(7):663-70. PubMed ID: 9715859 [TBL] [Abstract][Full Text] [Related]
54. Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) - A nationwide multicentre registry. Sponder M; Khazen C; Dichtl W; Fiedler L; Mörtl D; Teubl A; Steinwender C; Martinek M; Nürnberg M; Dalos D; Kastner J; Schukro C Eur J Intern Med; 2018 Feb; 48():64-68. PubMed ID: 28978409 [TBL] [Abstract][Full Text] [Related]
55. Is the last before-death alert remote monitoring transmission in patients with heart failure life-threatening? Dyrbuś M; Tajstra M; Kurek A; Pyka Ł; Gąsior M Kardiol Pol; 2022; 80(3):286-292. PubMed ID: 35040485 [TBL] [Abstract][Full Text] [Related]
56. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A; Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817 [TBL] [Abstract][Full Text] [Related]
57. Activation of remote monitoring for cardiac implantable electronic devices: small dog for tall weeds. D'Ancona G; Safak E; Senges J; Hochadel M; Nguyen VL; Perings C; Jung W; Spitzer S; Eckardt L; Brachmann J; Seidl K; Hink HU; Ince H; Ortak J Clin Res Cardiol; 2017 Oct; 106(10):833-839. PubMed ID: 28593341 [TBL] [Abstract][Full Text] [Related]
58. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy. Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043 [TBL] [Abstract][Full Text] [Related]
59. Incidence and predictors of appropriate therapies delivered by the implantable cardioverter defibrillator in patients with ischemic cardiomyopathy: a systematic review. Gracieux J; Sanders GD; Pokorney SD; Lopes RD; Thomas K; Al-Khatib SM Int J Cardiol; 2014 Dec; 177(3):990-4. PubMed ID: 25449512 [TBL] [Abstract][Full Text] [Related]
60. Analysis of arrhythmic events is useful to detect lead failure earlier in patients followed by remote monitoring. Nishii N; Miyoshi A; Kubo M; Miyamoto M; Morimoto Y; Kawada S; Nakagawa K; Watanabe A; Nakamura K; Morita H; Ito H J Cardiovasc Electrophysiol; 2018 Mar; 29(3):463-470. PubMed ID: 29194831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]